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Improving HIV test uptake and case finding with
assisted partner notification services
Shona Dalala, Cheryl Johnsona, Virginia Fonnerb, Caitlin E. Kennedyc,
Nandi Siegfriedd, Carmen Figueroaa and Rachel Baggaleya
Objective: Despite the enormous expansion of HIV testing services (HTS), an estimated
40%ofpeoplewithHIV infection remain undiagnosed. To enhance the efficiencyofHTS,
new approaches are needed. The WHO conducted a systematic review on the effec-
tiveness of assisted partner notification in improving HIV test uptake and diagnosis, and
the occurrence of adverse events, to inform the development of normative guidelines.
Methods: We systematically searched five electronic databases through June 2016.We
also contacted experts in the field and study authors for additional information where
needed. Eligible studies compared assisted HIV partner notification services to passive
or no notification. Where multiple studies reported comparable outcomes, meta-
analysis was conducted using a random-effects model to produce relative risks (RRs)
or risk ratios and 95% confidence intervals (CIs).
Results: Of 1742 citations identified, four randomized controlled trials and six obser-
vational studies totalling 5150 index patients from eight countries were included. Meta-
analysis of three individually randomized trials showed that assisted partner notification
services resulted in a 1.5-fold increase in HTS uptake among partners compared with
passive referral (RR¼1.46; 95% CI: 1.22–1.75; I2¼0%). The proportion of HIV-
positive partners was 1.5 times higher with assisted partner notification than with
passive referral (RR¼1.47; 95% CI: 1.12–1.92; I2¼0%). Few instances of violence or
harm occurred.
Conclusion: Assisted partner notification improved partner testing and diagnosis of HIV-
positivepartners,with few reports ofharm.WHOstrongly recommendsvoluntaryassisted
HIV partner notification services to be offered as part of a comprehensive package of
testing and care. Copyright  2017 The Author(s). Published by Wolters Kluwer Health, Inc.
AIDS 2017, 31:1867–1876
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Introduction
HIV testing and counselling services (HTS) and the
availability of antiretroviral therapy have expanded
enormously over the past three decades. Starting with
diagnostic testing offered to people with symptoms
suggestive of HIV infection and antenatal testing, HTS
now encompasses a range of approaches such as
community, home-based, and mobile testing to reach
larger and more varied populations earlier in their course
of infection. As a result, by the end of 2015, 17 million
people with HIV infection were receiving antiretroviral
treatment [1]. Yet it is currently estimated that over
14.5 million people living with HIV worldwide remain
undiagnosed [2]. To address this gap – in particular, the
first of the UN 90-90-90 goals to diagnose 90% of people
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with HIV infection by 2020 [2] – new approaches that
enhance the efficiency of testing and increase the coverage
of treatment are needed. HIV partner notification is an
approach that has the potential to particularly identify
people with undiagnosed HIV infection who remain
unlinked to prevention, treatment and care services, and
continue to be at risk of transmitting HIV vertically or
through sexual and drug-injecting partners.
Assisted partner notification, or contact tracing has been
an important public health approach in communicable
disease management for decades, including in pro-
grammes for sexually transmitted infections (STIs) and
tuberculosis (TB). The tracing of contacts and the
voluntary screening of household members of patients
with pulmonary TB is an effective and standard approach
[3,4]. A 2013 Cochrane review found that expedited
partner therapy was more successful than simple patient
referral in preventing recurrent STIs causing urethritis or
cervicitis [5]. Although it is well known that the sexual
and drug-injecting partners of people diagnosed with
HIV infection have an increased probability of also being
HIV-positive [6–12], partner notification services for
people diagnosed with HIV have not been routinely
included in HTS policies internationally [13].
To inform a 2016 WHO HTS guidelines update, we
conducted a systematic review and meta-analysis of
partner notification services to determine their effec-
tiveness in the uptake of HTS, diagnosing partners and
linking them to care, and also to assess the occurrence of
adverse events or harm following partner notification.
Methods
We followed the methods described in the PRISMA
statement for the reporting of systematic reviews and
meta-analyses.
Search strategy and inclusion criteria
Through 1 June 2016, we searched five electronic
databases (PubMed, EMBASE, Cumulative Index to
Nursing and Allied Health Literature CINAHL, Psy-
cINFO, and Sociological Abstracts), and websites of
major HIV-related conferences for relevant abstracts
[International AIDS Conference (IAC), Conference on
HIV Pathogenesis, Treatment, and Prevention (IAS), and
Conference on Retroviruses and Opportunistic Infections
(CROI)]. The IAC and IAS conference abstracts were
searched for all available years; for CROI, only the most
recent conferences (2014, 2015, and 2016) were searched
as past conference abstracts were inaccessible online. In
addition, selected experts in the field were contacted, and
secondary reference searching was conducted on all
included studies as well as on relevant review articles
[5,14,15] to identify additional articles and abstracts. We
also searched for ongoing randomized controlled trials
(RCTs) through clinicaltrials.gov, the WHO International
Clinical Trials Registry Platform (www.who.int/ictrp/),
and the Pan African Clinical Trials Registry (www.pactr.
org). We contacted study authors when additional
information was needed.
A comprehensive PubMed search strategy was adapted for
entry into all computer databases and included terms for
HIVand partner notification and was not limited by study
design: (HIV [tiab] OR ‘human immunodeficiency virus’
[tiab]) AND (‘contact examination’ [tiab] OR ‘contact
detection’ [tiab] OR ‘contact tracing’ [tiab] OR ‘partner
notification’ [tiab] OR ‘partner notifications’ [tiab] OR
‘partner tracing’ [tiab] OR ‘partner services’ OR ‘partner
counseling and referral services’ [tiab]). No language or
geographic limitations were placed on the search.
To be included, an article had to meet the following
criteria: a study design that compared persons who
received HTS and were diagnosed HIV-positive and who
were offered partner notification services using assistance
(such as contract or provider referral) to such persons who
received HTS with passive referral or no partner
notification intervention; measured one or more of the
primary or secondary outcomes; and was published in a
peer-reviewed journal or conference abstract.
Partner notification approaches included: first, passive
referral, where HIV-positive clients are encouraged to
disclose their status and suggest HIV testing to their
partner(s) on their own; and assisted approaches: second,
contract referral, where HIV-positive clients enter into a
contract with a provider to refer their partner(s) to HTS
within an agreed time period, after that the provider
contacts the partner(s) directly and offers HTS, while
maintaining the anonymity of the index patient. Third
Provider referral, where providers directly contact partners
of index patients to offer HTS, and fourth, dual referral
where the provider accompanies the index patient when
they disclose their status and offers HTS to their partner(s).
Outcomes
Outcomes were: uptake of HTS among partner(s) of
HIV-positive index patients; proportion of partners who
tested for HIV and were diagnosed HIV-positive; any
experience of social harm/adverse events among HIV-
positive patients and/or their partners; measurement of
CD4þ cell count or viral load among partners; linkage to
clinical assessment or ART among partners following
HIV-positive diagnosis; and linkage to a prevention visit
among partners after an HIV-negative test result.
Screening and data extraction
Screening was conducted in a two-stage process. First,
titles, abstracts, and citation information identified
through the search strategy were screened to remove
clearly nonrelevant articles. Full-text articles for all
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selected abstracts were then screened by two independent
reviewers for eligibility. Differences were resolved
through consensus. Data were extracted into standardized
coding forms.
Statistical analysis
Data were analysed according to partner notification
approach and outcome. Where multiple RCTs reported
the same or comparable outcomes and were considered
methodologically and clinically appropriate to combine,
meta-analysis was conducted using a random-effects model
to produce relative risks (RRs) (or rate ratios where
applicable) and 95% confidence intervals (CIs) for
dichotomous data using REVMAN version 5.3 (The
Nordic Cochrane Centre, The Cochrane Collaboration,
Copenhagen, Denmark). We conducted analyses using
either all identified partners or all locatable partners as the
denominator. For uptake of partner testing and linkage to
care, we also analysed the rate ratio of partners tested to
index patients to address the attrition of partners between
those identified by index patients to those located and
notified.
Quality and Grading of Recommendations,
Assessment, Development and Evaluation
assessments
For individual RCTs, the risk of bias was evaluated using
the Cochrane Collaboration’s tool for assessing risk of bias
[16]. We used Grading of Recommendations, Assess-
ment, Development and Evaluation (GRADE) to
determine the overall quality of evidence for each
outcome measured in the RCTs. GRADE includes an
appraisal of the risk of bias, imprecision, indirectness,
inconsistency, and publication bias across included trials
to inform an overall grading of high, moderate, low, or
very low quality of evidence [17].
Role of the funding source
The funders had no role in the development of this study.
The authors alone were responsible for the study design,
data collection, analysis, interpretation, and writing of the
article. The corresponding author had the final respon-
sibility for the decision to submit for publication.
Results
The searches yielded 1742 citations; four RCTs (three
individually randomized trials and one cluster-random-
ized) met our eligibility criteria (Fig. 1). We included
observational studies that compared types of partner
notification services but either did not randomize index
patients or did not have a nonintervention control arm, in
order to provide an indication of broader geographic and
population types for the main outcomes; these were not
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Fig. 1. Study selection.
included in meta-analyses. For one cluster RCT [11] and
observational study [18], we included results from a
conference abstract in addition to results subsequently
published in a peer-reviewed article [19,20], respectively,
that were made available after the cut-off date for our
initial search.
RCTs were conducted in the United States [8], Malawi
[7,9], and Kenya [19]; the largest and most recent were in
sub-Saharan Africa. Three RCTs compared assisted
partner notification services (provider or contract referral)
with passive approaches, and the fourth cluster RCT
compared immediate assisted notification with a passive
referral group that received delayed assisted partner
notification after outcomes were assessed. The study
populations included pregnant women attending ante-
natal care [9], patients from STI clinics [7], clients from an
HIV testing centre [19], and patients in a United States
county health department that included women, men
who have sex with men (MSM), and people who inject
drugs [8]. Six observational studies were conducted
among the general population in Cameroon [21],
Mozambique [20], Spain [22], the United Republic of
Tanzania [23], and the United States [24], across a variety
of healthcare settings and HIV testing sites (Table 1). All
studies utilized multiple methods to contact and notify
partners, including telephone calls, messages, and in-
person visits.
The 10 studies included in our review were published
between 1992 and 2016, and included a total of 5150
index patients who identified a total of 6127 partners (one
study [9] provided only one partner invitation per index
patient). On average, HIV-positive index patients named
2.0 partners, but this varied dramatically between studies
(range 0.58–5.58); the largest were among key popu-
lation groups (defined as MSM, people who inject drugs,
sex workers, people in prisons, or transgender people). In
the nine studies reporting outcomes by approach, the
ratio of partners who tested for HIV per index patient was
on average 0.45 (range 0.01–1.19) for passive referral, and
0.85 (range 0.19–1.81) for assisted partner notification
(Table 1). A partner notification cascade using five studies
which reported each step starting from the ratio of
partners identified through to the number of partners
newly identified as HIV positive per index patient, shows
the progressive loss to follow-up of partners, the largest
being between partner identification and notification
(Fig. 2). On average, 1.14 (range 0.26–4.37) partners
were notified per index patient following passive referral
and 1.86 (range 0.93–4.03) with assisted notification.
Meta-analysis of the three individually randomized trials
using all identified partners as the denominator, showed
that assisted partner notification services resulted in a
1.5-fold increase in the uptake of HTS among partners
compared with passive referral (RR¼ 1.46; 95% CI:
1.22–1.75; Fig. 3a) [7–9,19]. Meta-analysis restricted to
partners who could be located in the denominator
found a similar beneficial effect. Statistical heterogeneity
was high (RR¼ 1.39; 95% CI: 0.93; 2.06; Chi2 for
heterogeneity¼ 8.34; df¼ 2; I2¼ 76%) (Appendix
Fig. A1, http://links.lww.com/QAD/B115). When all
four RCTs were included in a meta-analysis of the rate of
partner testing and return of partners to the clinic per
index case, the rate ratio of the assisted partner notification
group was twice that of those in the passive referral group
(rate ratio: 2.04; 95% CI: 1.11–3.77; chi2 for hetero-
geneity¼ 60.84; df¼ 3; I2¼ 95%) (Fig. 3b). GRADE
quality evidence was rated moderate for all analyses of
HIV testing uptake due to the lack of blinding across
studies, and attrition. In five observational studies, assisted
partner notification was associated with increased uptake
of HTS among identified partners compared with passive
referral [20–22,24].
The proportion of partners of index patients who tested
HIV-positive ranged from 20 to 72% in both passive and
assisted arms of the four trials (Table 1) [7–9,19]. Among
the observational studies, the highest proportion testing
HIV positive was 86%. In the four studies [7,9,20,21] that
reported on couples, between 29 and 40% were in
serodiscordant partnerships. A meta-analysis of the three
individually RCTs found that the proportion of all
identified partners who were HIV-positive following
testing was 1.5 times higher in the assisted partner
notification approach than in the passive approach
(RR¼ 1.47; 95% CI: 1.12–1.92) (Fig. 4). In sensitivity
analyses, the results were similar using locatable partners
as the denominator (RR¼ 1.49; 95% CI: 1.14–1.95)
(Appendix Fig. A2, http://links.lww.com/QAD/B115).
The percentage of partners newly diagnosed with HIV
among partners who could be located, was higher with
provider assisted partner notification (RR¼ 1.37; 95%
CI: 0.98–1.93) (Appendix Fig. A6, http://links.lww.
com/QAD/B115), and was similar when the cluster
RCT was included in analyses with high statistical
heterogeneity (Appendix Fig. A3, http://links.lww.com/
QAD/B115). Across the observational studies, 0 to 86%
of partners of HIV-positive individuals were newly
diagnosed with HIV [20–24]. An observational study in
Mozambique reported a two-fold increase in the
percentage of partners diagnosed with HIV when passive
approaches were replaced by assisted partner referral [20].
Meta-analysis of the two trials which reported on linkage
to care showed that there was a higher rate of linkage to
care in HIV-positive partners in the provider referral arm
than in the passive arm (rate ratio¼ 3.76; 95% CI: 2.41–
5.86; chi2 for heterogeneity¼ 1.48; df¼ 1; I2¼ 33%))
(Appendix Fig. A4, http://links.lww.com/QAD/B115)
[9,19].
All four trials and two observational studies reported few
(0–3%) instances of harm resulting from partner
1870 AIDS 2017, Vol 31 No 13
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notification [7–9,19–21]. A meta-analysis of two
individually randomized and one cluster-randomized
trial, showed no difference in social harm or adverse
events comparing assisted and passive partner notification
(RR¼ 1.86; 95% CI: 0.37–9.50) (Appendix Fig. A5,
http://links.lww.com/QAD/B115). Reported incidents
of harm in RCTs in Kenya and Malawi appeared not to
be associated with HIV partner notification services, as
they occurred prior to the intervention [9,19].
A single RCT [7] compared contract referral with passive
referral. The quality of evidence was graded as very low
for all outcomes as it was a single study, there was a lack of
blinding of staff and participants, and results were
imprecise. Results showed that assisted partner notifica-
tion services using contract referral resulted in a two-fold
increase in test uptake among the partners of HIV-
positive individuals compared with passive referral
(RR¼ 2.08; 95% CI: 1.33–3.25). The proportion of
identifiable partners who tested for HIV and were
diagnosed HIV positive was higher for contract referral
than passive referral (RR¼ 1.91; 95% CI: 1.07; 3.40).
Sensitivity analyses were comparable (data not shown).
Discussion
When HIV positive index patients were offered assistance
in notifying their sexual and drug-injecting partners of
their exposure to HIV infection, our analyses show that it
resulted in higher uptake of partner HIV testing,
identified higher proportions of HIV-infected persons,
and increased linkage to care through the referral of newly
identified HIV-infected partners to ART services.
Although there were few RCTs in our meta-analyses,
the results are consistent towards favouring assisted
approaches, as are the results from observational studies
with control groups. Across all studies, high proportions
of partners returned for HIV testing when contacted by a
provider, whichever method was used. Overall, index
patients identified an average of two partners each and this
resulted in 0.44 (range 0.01–1.8) partners per index
patient eventually testing, following attrition between
identified and notified partners, and acceptance of testing.
The proportion of partners who tested HIV positive
following assisted notification across all studies ranged
from 12 to 86%, and between 29 and 40% of couples
were serodiscordant.
Although all the studies that were reviewed showed
improved outcomes with assisted partner notification
approaches in both RCTs and observational studies,
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Fig. 3. Uptake of HIV testing among partners of index cases assessed with: (a) HIV testing and return to clinic – meta-analysis
using all identified partners as the denominator. (b) Rate of partner test or return to clinic of partner per index patient – meta-
analysis using generic inverse variance.
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Fig. 2. Partner notification cascade from five studies report-
ing data for each step [8,11,23–25].
passive referral also resulted in uptake of HIV testing
among partners (range 2–65%) [7–9,20,22,23]. In some
studies, HIV test uptake in the passive group was seen at a
similar or higher level to that of assisted approaches from
other studies. Two studies with very low HTS uptake in
the passive referral groups were conducted in the United
States before triple therapy was available (3% testing
uptake) [8], and when implementation of partner
notification reporting regulations appeared to be low
(2% test uptake) [24]. The remaining studies presenting
this information reported HIV test uptake between 24
and 65% [7,9,19,20,22,23,25]. Furthermore, observa-
tional data from Cameroon demonstrate the scalability of
partner notification with the offer of multiple notification
approaches to index patients in a programmatic setting,
resulting in high partner test uptake overall (67%) [21].
Thus, the simple act of encouraging partner notification
and offering services to a person who is HIV positive,
whether verbally during counselling, or through written
invitation letters or referral cards, is beneficial, and could
be considered while assisted approaches are being brought
to scale. Linkage to care for partners who test HIV
positive was higher with assisted partner notification
methods than with passive methods in both RCTs [9,19]
and observational studies [21,23].
The ratio of partners tested per index patient varies, but in
all studies, a substantial drop occurs between identified
and notified partners and may be due to the difficulty in
contacting partners. One of the challenges to partner
notification has been that key populations [26] and
people with casual partners [7,27] may be less able or
willing to identify partners; spouses and steady partners
have been more likely to be notified than other partners
[7,21,28–30]. Recall of, and contact information for,
partners was reported to be better among heterosexual
women than among MSM or people who inject drugs in
one study [31]. Yet, as was found in studies conducted
among the general population, assisted partner notifica-
tion services among key populations resulted in higher
uptake of HTS, and particularly among MSM and people
who inject drugs, also identified a high proportion of
HIV-positive partners (5–80%) [32–54]. A recently
published observational study found that 36% of newly
diagnosed partners had acute or early HIV infection,
and among partners with genetic sequences, 61% were
genetically linked to the index patient, emphasizing the
importance of reaching partners to prevent transmission
in discordant partnerships [55]. Providing partner
notification to key populations and those with casual
partners may require more intensive efforts to locate
partners, including the assurance of confidentiality and
anonymity for HIV-positive clients.
Reported social harm and other adverse events following
HIV partner notification, using passive or assisted
approaches, have been rare. Fears about social harm
following disclosure or partner notification are of
particular concern in situations where certain behaviours
associated with HIV infection are criminalized, such as
among people who inject drugs, or where one partner is
economically dependent on the other and fears losing
social or financial support. However, although issues
around confidentiality [56], and mostly hypothetical
concerns about potential harm [57,58] have been raised in
the literature, when adverse events have actually been
measured, very few have occurred [7–9,19]. Moreover,
studies from the United States showed no differences in
partnership dissolution following HIV partner notifica-
tion when compared with a high-risk HIV-negative
control group [59], or to syphilis partner notification [28].
Some studies screened for intimate partner violence (IPV)
and excluded those persons with a history of IPV, which
would put them at risk of harm following disclosure.
Reported incidents of harm in RCTs in Kenya and
Malawi appeared not to be associated with HIV partner
notification services, as they occurred prior to the
intervention [9,19]. Although programme implementers
should be sensitive to the potential for harm arising from
disclosure of HIV status and assisted partner notification,
this should be balanced against the benefit of diagnosing
HIV infection and linking people to treatment. These
results were obtained from a limited number of studies
undertaken in the United States and Africa; studies from
other world regions are needed.
Our review identified four RCTs with which to assess the
effectiveness of HIV partner notification services with the
quality of evidence for the primary outcome graded as
moderate. For some outcomes, significant statistical
heterogeneity was present, mostly driven by the large
effects observed in the cluster-randomized trial. We
conducted sensitivity analyses to test the robustness of the
results, using different denominators and methods of
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Fig. 4. Proportion of partners who tested and were diagnosed HIV positive – meta-analysis using all identified partners as the
denominator.
outcome measurement and found consistent results. One
trial [8] was conducted before the advent of combination
antiretroviral therapy and was the only one which
included key populations, and assessed outcomes by two
assisted approaches (provider and contract referral);
excluding it would have strengthened the impact of
partner notification interventions. Although included
data were derived from RCTs, evaluation of the quality of
the evidence using the GRADE approach identified a
high risk of performance and detection bias due to a lack
of blinding across trials, attrition, and in some instances,
imprecision and data arising from a single study. Despite
these limitations, our result for the main outcome of HIV
test uptake was clear and consistent, with observational
data also indicating that assisted partner notification was
beneficial. The pooled synthesis on social harm indicated
very few events. The quality of evidence was downgraded
due to imprecision and risk of bias, but when considered
with similarly few adverse events from observational
data, it suggests that the rate of social harm is not likely to
differ between assisted and passive partner notification
approaches.
In conclusion, our findings show that assisted partner
notification increased HIV test uptake and diagnosed high
proportions of people with HIV infection, with very few
reports of harm. The difficulty in tracing identified
partners may have resulted in the low ratio of partners
notified per index patient. However, the high proportion
of partners who were HIV positive among those who
were notified warrants the efforts needed to reach
partners for testing. Furthermore, treatment for infected
partners is critical to prevent transmission to seronegative
partners for those in serodiscordant partnerships. Assisted
HIV partner notification should be implemented as a
routine part of HTS and should be offered to all newly
diagnosed persons, and periodically to all HIV positive
persons throughout their care and treatment.
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